TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3729199

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (6.5 and 13 micrograms/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg, 30 minutes before breakfast)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30407633

Group type: EXPERIMENTAL
Intervention: High-oleic canola oil supplemented with DHA (HOCO-DHA)
Number of subjects: 129

Group type: COMPARATOR
Intervention: High-oleic canola oil (HOCO)
Number of subjects: 129
Study: 28106573

Group type: EXPERIMENTAL
Intervention: Ankle strengthening exercise integrated rTMS (group II)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ankle strengthening exercise (group I)
Number of subjects: 30

Group type: COMPARATOR
Intervention: rTMS (control group)
Number of subjects: 30
Study: 26814458

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine-1% thymol varnish
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10% fluoride varnish
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 12
Study: 24697031

Group type: EXPERIMENTAL
Intervention: Patients with prostate cancer (CaP)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group of healthy men
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Patients with low severity of CaP (T1)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Patients with higher tumor stage (T2+T3+T4)
Number of subjects: 42
Study: 22025997

Group type: EXPERIMENTAL
Intervention: OFD + OCHS (test)
Number of subjects: 30

Group type: COMPARATOR
Intervention: OFD (control)
Number of subjects: 30
Study: 18287817

Group type: EXPERIMENTAL
Intervention: High-rolling-resistance (RR) training method
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional training method
Number of subjects: 48
Study: 16469442

Group type: EXPERIMENTAL
Intervention: Citalopram (CIT) 40 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Melatonin (MT) 1 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12680886

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (FP) 1000 microg day‐1 for 7 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intravenous fluticasone propionate 1000 microg
Number of subjects: 10
Study: 10846595

Group type: EXPERIMENTAL
Intervention: Genotype-guided treatment
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard of care (control arm)
Number of subjects: 108
Study: 9106575

Group type: EXPERIMENTAL
Intervention: Pari LC nebulizer system (300 mg tobramycin in 5 mL of 1/4 normal saline)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Sidestream nebulizer system (300 mg tobramycin in 5 mL of 1/4 normal saline)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: UltraNeb 99/100 nebulizer system (600 mg tobramycin in 30 mL of 1/2 normal saline)
Number of subjects: 68
Study: 8229026

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Combination of prednisone and azathioprine
Number of subjects: 41
Study: 31104856

Group type: EXPERIMENTAL
Intervention: 20 mg of levo-pantoprazole
Number of subjects: 30

Group type: COMPARATOR
Intervention: 40 mg of racemic pantoprazole
Number of subjects: 30
Study: 30824296

Group type: EXPERIMENTAL
Intervention: PSA screening
Number of subjects: 182160
Study: 27401537

Group type: EXPERIMENTAL
Intervention: PrEP awareness
Number of subjects: 759

Group type: EXPERIMENTAL
Intervention: PrEP use
Number of subjects: 759

Group type: EXPERIMENTAL
Intervention: Condomless anal sex partners (PrEP-users)
Number of subjects: 759

Group type: EXPERIMENTAL
Intervention: Condomless anal sex acts (PrEP-users)
Number of subjects: 759
Study: 25731180

Group type: EXPERIMENTAL
Intervention: Brief motivational intervention for substance misuse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not applicable (intervention effect)
Number of subjects: 0
Study: 24315475

Group type: EXPERIMENTAL
Intervention: 80-kV tube voltage
Number of subjects: 120

Group type: COMPARATOR
Intervention: 120-kV tube voltage
Number of subjects: 120
Study: 22339386

Group type: EXPERIMENTAL
Intervention: RelyX Unicem
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Panavia F 2.0
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Variolink II
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (saline solution storage)
Number of subjects: 66
Study: 20146701

Group type: EXPERIMENTAL
Intervention: Rimonabant 20 mg/day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 17564853

Group type: EXPERIMENTAL
Intervention: CPAT program (computerized progressive attentional training)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (computer games)
Number of subjects: 36
Study: 16359283

Group type: EXPERIMENTAL
Intervention: Full antibradycardia pacemaker system implantation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Full antibradycardia pacemaker system implantation and generator only implantation
Number of subjects: 40
Study: 12011824

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Dobutamine and Norepinephrine
Number of subjects: 22
Study: 9469347

Group type: EXPERIMENTAL
Intervention: Pamidronate 90 mg intravenously administered as a 4-hour infusion monthly for 21 cycles
Number of subjects: 392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Pamidronate (stratum 2 patients)
Number of subjects: 392

Group type: COMPARATOR
Intervention: Placebo (stratum 2 patients)
Number of subjects: 392
Study: 8585642

Group type: EXPERIMENTAL
Intervention: Mupirocin ointment alone
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Mupirocin ointment plus chlorhexidine baths
Number of subjects: 52
Study: 2096108

Group type: EXPERIMENTAL
Intervention: Heptaminol (626 mg dose)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 582541

Group type: EXPERIMENTAL
Intervention: 3 mg of pimozide
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 8 mg of pimozide
Number of subjects: 2

Group type: COMPARATOR
Intervention: Both groups (3 mg and 8 mg)
Number of subjects: 2
Study: 30136042

Group type: EXPERIMENTAL
Intervention: Practice-plus-exposure regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Practice regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exposure regimen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Posttest performance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naïve comparison performance
Number of subjects: 0
Study: 29967221

Group type: EXPERIMENTAL
Intervention: Fitbit + MapTrek group
Number of subjects: 146

Group type: COMPARATOR
Intervention: Fitbit-only group
Number of subjects: 146
Study: 26711509

Group type: EXPERIMENTAL
Intervention: PfSPZ chemoprophylaxis vaccine (CVac) - 3× monthly immunizations with 7.5 × 10(4) PfSPZ
Number of subjects: 65

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: PfSPZ chemoprophylaxis vaccine (CVac)
Number of subjects: 65
Study: 24174392

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 5018

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 5018
Study: 22718043

Group type: EXPERIMENTAL
Intervention: Location-targeted AdWords intervention
Number of subjects: 3752

Group type: EXPERIMENTAL
Intervention: User-stated postcode assessment
Number of subjects: 3752

Group type: EXPERIMENTAL
Intervention: Google AdWords targeting accuracy
Number of subjects: 3752
Study: 19196113

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) - 12 J (4 J/cm²) applied intraorally and extraorally immediately after surgery
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo - handpiece applied without laser activation
Number of subjects: 32
Study: 17093916

Group type: EXPERIMENTAL
Intervention: Tropisetron plus metopimazine
Number of subjects: 82

Group type: COMPARATOR
Intervention: Tropisetron plus placebo
Number of subjects: 82
Study: 15207420

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise program (combination of aerobic/endurance activities, strength training, balance, and flexibility training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise program
Number of subjects: 0
Study: 11394594

Group type: EXPERIMENTAL
Intervention: Anterior cruciate ligament reconstruction
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control knees (normal knees)
Number of subjects: 15
Study: 9473535

Group type: EXPERIMENTAL
Intervention: MTBE vapor exposure at 5, 25, and 50 ppm for 2 hours during light physical exercise.
Number of subjects: 10
Study: 7734470

Group type: EXPERIMENTAL
Intervention: Imipramine 150 mg/day
Number of subjects: 183

Group type: COMPARATOR
Intervention: Imipramine 10 mg/day (control)
Number of subjects: 183
Study: 2687898

Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil 20 mg/kg/day
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil 40 mg/kg/day
Number of subjects: 31

Group type: COMPARATOR
Intervention: Cefaclor 30 mg/kg/day
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil (both doses)
Number of subjects: 31
Study: 31694642

Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) intervention delivered by telephone following a six-topic protocol
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) intervention
Number of subjects: 443
Study: 27797396

Group type: EXPERIMENTAL
Intervention: Doxycycline 40 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Minocycline 100 mg
Number of subjects: 80
Study: 25280132

Group type: EXPERIMENTAL
Intervention: Mobile-bearing (MB) total knee arthroplasty
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fixed-bearing (FB) total knee arthroplasty
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (FB and MB)
Number of subjects: 50
Study: 24368488

Group type: EXPERIMENTAL
Intervention: Porcine dermis
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Polypropylene mesh
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 81
Study: 22646698

Group type: EXPERIMENTAL
Intervention: BAF312
Number of subjects: 48
Study: 18848939

Group type: EXPERIMENTAL
Intervention: Maintenance peginterferon for 3.5 years
Number of subjects: 1005

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 1005

Group type: EXPERIMENTAL
Intervention: Patients with cirrhosis
Number of subjects: 1005

Group type: EXPERIMENTAL
Intervention: Patients with bridging fibrosis
Number of subjects: 1005

Group type: EXPERIMENTAL
Intervention: Patients with serial biopsy specimens showing only fibrosis
Number of subjects: 1005
Study: 17943443

Group type: EXPERIMENTAL
Intervention: Postmenopausal hormone therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern
Number of subjects: 0
Study: 16385102

Group type: EXPERIMENTAL
Intervention: Combination analgesic therapy; specific drugs and dosages not available.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individual component drugs; specific drugs and dosages not available.
Number of subjects: 0
Study: 12626202

Group type: EXPERIMENTAL
Intervention: Corline Heparin Surface (CHS) with standard level of heparin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Corline Heparin Surface (CHS) with high level of heparin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Uncoated oxygenators
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Corline Heparin Surface (CHS) with low level of heparin
Number of subjects: 60
Study: 10520620

Group type: EXPERIMENTAL
Intervention: Pear juice (120 mL)
Number of subjects: 14

Group type: COMPARATOR
Intervention: White grape juice (120 mL)
Number of subjects: 14
Study: 7863649

Group type: EXPERIMENTAL
Intervention: Nurse-administered bed bath
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Passive range-of-motion exercises
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Turning from side to side
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nurse-administered interventions (overall)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Order of interventions
Number of subjects: 30
Study: 1937599

Group type: EXPERIMENTAL
Intervention: Kshaarasootra (Ayurvedic medicated thread)
Number of subjects: 502

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 502
Study: 7075123

Group type: EXPERIMENTAL
Intervention: Methadone (35 to 80 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Methadone (10 and 20 mg/day)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 31911516

Group type: EXPERIMENTAL
Intervention: mHealth based and three‐tiered diabetes management system
Number of subjects: 19008

Group type: COMPARATOR
Intervention: Usual care as EPHS packaged
Number of subjects: 19008
Study: 31771598

Group type: EXPERIMENTAL
Intervention: Supplement containing caffeine, theanine and tyrosine (SUP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 20
Study: 29229808

Group type: EXPERIMENTAL
Intervention: LLINs + IRS with deltamethrin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LLINs + IRS with bendiocarb
Number of subjects: 0

Group type: COMPARATOR
Intervention: LLINs alone
Number of subjects: 0
Study: 26228414

Group type: EXPERIMENTAL
Intervention: High-dose antidepressant therapy
Number of subjects: 333

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Low-dose antidepressant therapy
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: All doses (high, low, placebo)
Number of subjects: 333
Study: 23357491

Group type: EXPERIMENTAL
Intervention: Positive diagnostic strategy (analyses of blood cell count and C-reactive protein)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Strategy of exclusion (analyses of blood, stool samples for intestinal parasites, and sigmoidoscopies with biopsies)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Positive diagnostic strategy
Number of subjects: 302

Group type: COMPARATOR
Intervention: Strategy of exclusion
Number of subjects: 302
Study: 20718623

Group type: EXPERIMENTAL
Intervention: Yoga (30-minute session)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (20-minute session on a bicycle ergometer)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No exercise control condition
Number of subjects: 40
Study: 19524832

Group type: EXPERIMENTAL
Intervention: Hawley retainer
Number of subjects: 50

Group type: COMPARATOR
Intervention: perfector/spring aligner retainer
Number of subjects: 50
Study: 17307888

Group type: EXPERIMENTAL
Intervention: Exercise training group (n = 19) allowed to continue Achilles tendon-loading activity (running and jumping) with a pain-monitoring model
Number of subjects: 38

Group type: COMPARATOR
Intervention: Active rest group (n = 19) had to stop tendon-loading activities during the first 6 weeks
Number of subjects: 38
Study: 15277916

Group type: EXPERIMENTAL
Intervention: Sex-based formula (size 4 for women and size 5 for men)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Weight-based formula (size 3 for weight < 50 kg, size 4 for weight 50‐70 kg, and size 5 for weight > 70 kg)
Number of subjects: 237
Study: 11557703

Group type: EXPERIMENTAL
Intervention: Nurse assessment with reinforcement of pelvic floor muscle training exercises and bladder training
Number of subjects: 747
Study: 9489594

Group type: EXPERIMENTAL
Intervention: 0.4 mg tamsulosin (as Omnic modified release capsules)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 5 mg terazosin (as Flotrin tablets)
Number of subjects: 2
Study: 7523546

Group type: EXPERIMENTAL
Intervention: CYFRA 21-1
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: CYFRA 21-1 + TPA
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: CYFRA 21-1 + NSE
Number of subjects: 629

Group type: COMPARATOR
Intervention: NSE
Number of subjects: 629
Study: 3254832

Group type: EXPERIMENTAL
Intervention: AWD 26‐06 (50 mg and above)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: AWD 26‐06 (100 mg and 150 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: AWD 26‐06 (150 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: AWD 26‐06 (25 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 29298868

Group type: EXPERIMENTAL
Intervention: Bimodal auditory-somatosensory stimulation for 28 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bimodal auditory-somatosensory stimulation for 20 minutes per day for 25 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unimodal auditory stimulation
Number of subjects: 20
Study: 28323763

Group type: EXPERIMENTAL
Intervention: Reamer-Irrigator-Aspirator (RIA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard Reaming (SR)
Number of subjects: 22
Study: 26691357

Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone acetonide (10 mg/ml)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Topical betamethasone valearate cream 0.1% twice daily
Number of subjects: 226
Study: 23434331

Group type: EXPERIMENTAL
Intervention: Unpreserved timolol 0.1% gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preserved latanoprost 0.005%
Number of subjects: 0
Study: 22036927

Group type: EXPERIMENTAL
Intervention: Video link for telemedicine consultations
Number of subjects: 60

Group type: COMPARATOR
Intervention: Telephone call with viewing of digital X-ray images (PACS)
Number of subjects: 60
Study: 19470803

Group type: EXPERIMENTAL
Intervention: Combined resistance and aerobic training (BRE group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Protein supplementation (BRN group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bed rest control (BRC group)
Number of subjects: 24
Study: 16713059

Group type: EXPERIMENTAL
Intervention: Glucose administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspartame control
Number of subjects: 0
Study: 15259840

Group type: EXPERIMENTAL
Intervention: Fluoxetine plus cognitive-behavioural therapy (CBT+meds)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Fluoxetine (meds only)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Both treatment groups (CBT+meds and meds only)
Number of subjects: 132
Study: 11720060

Group type: EXPERIMENTAL
Intervention: Stanford Heart Attack Staying Free (SF) programme
Number of subjects: 198

Group type: COMPARATOR
Intervention: Usual Care (UC) programme
Number of subjects: 198
Study: 14655830

Group type: EXPERIMENTAL
Intervention: 1 g L-tryptophan
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2 g L-tryptophan
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 3 g L-tryptophan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 20
Study: 7951084

Group type: EXPERIMENTAL
Intervention: Salbutamol (400 micrograms per day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Salbutamol (400 micrograms per day) + Beclocort (1 mg per day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Salbutamol (400 micrograms per day) + Nedocromil (Tilade 8 mg per day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Salbutamol alone or in combination with an anti-inflammatory agent
Number of subjects: 20
Study: 2660997

Group type: EXPERIMENTAL
Intervention: Zinc chloride spray and magnesium hydroxide ointment applied twice daily for seven consecutive days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31618267

Group type: EXPERIMENTAL
Intervention: Twitter group (case)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 189
Study: 28277603

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg subcutaneously every 6 months during the FREEDOM trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Denosumab during the FREEDOM Extension (Crossover Group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Denosumab during the FREEDOM Extension (Long-term Group)
Number of subjects: 0
Study: 25636792

Group type: EXPERIMENTAL
Intervention: Doppler
Number of subjects: 1971

Group type: COMPARATOR
Intervention: Pinard
Number of subjects: 1971
Study: 23408299

Group type: EXPERIMENTAL
Intervention: Telemonitoring
Number of subjects: 205

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 205
Study: 21493792

Group type: EXPERIMENTAL
Intervention: Intensive lipid therapy
Number of subjects: 28
Study: 19112757

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 16442916

Group type: EXPERIMENTAL
Intervention: BNP group (n = 119)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Clinical group (n = 107)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 226
Study: 15274684

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg daily
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg daily
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combination of enalapril 10 mg and losartan 100 mg daily
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 33
Study: 11016325

Group type: EXPERIMENTAL
Intervention: Eptifibatide (180 microg/kg bolus plus 2 microg/kg/min infusion)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 8872656

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) - 75 g glucose solution ingested 30 min before exercise
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (Con) - sweet placebo solution ingested 30 min before exercise
Number of subjects: 6
Study: 1618465

Group type: EXPERIMENTAL
Intervention: Sodium benzoate (5 gm twice daily)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Lactulose (dose adjusted for 2 or 3 semiformed stools/day)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 74
Study: 6662184

Group type: EXPERIMENTAL
Intervention: tienilic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: hydrochlorothiazide-amiloride combination
Number of subjects: 0
Study: 31965649

Group type: EXPERIMENTAL
Intervention: Single-dose cefazolin
Number of subjects: 203

Group type: COMPARATOR
Intervention: Multiple-dose cefazolin (3 days)
Number of subjects: 203